Health Condition 1: H102- Other acute conjunctivitis
Conditions
Interventions
Intervention1: Tobramycin and dexamethasone combination eyedrop: Patients will be assigned to one of two groups using a computer-generated random number table. Group A will receive a combination of to
Sponsors
Sadguru Netra Chikitsalaya
Eligibility
Inclusion criteria
Inclusion criteria: Treatment naïve patients with recent onset of the presumed viral conjunctivitis (presenting within 5 days) and consenting to participate in the study will be included.
Exclusion criteria
Exclusion criteria: Patients with age <8 years, diffuse hemorrhagic conjunctivitis, conjunctivitis having matted eyelashes/ purulent discharge/ membrane or pseudo membrane/ lid infections like stye and chalazion, corneal involvement, anterior segment inflammation, prior history of viral keratitis, glaucoma or steroid responder, who do not adhere to the study follow- up schedule and mentally subnormal patients who are unable to express symptoms severity will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the proportion of patients getting complete relief (symptom score 0) in the ‘study eye’ after 48 hours & 7 days of starting treatment.Timepoint: 48 hours & 7 days of starting treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Partial relief in terms of reduction of symptom scoresTimepoint: 48 hours & 7 days of starting treatment;proportion of patients developing adverse events & the subsequent need for change in treatment.Timepoint: 48 hours & 7 days of starting treatment | — |
Countries
India
Contacts
Public ContactAmruta More
Sadguru Netra Chikitsalaya
Outcome results
None listed